Invent Medic announces that the company is now establishing its product Efemia Bladder Support in the UK together with the distributor Advanced Global Health. The launch is planned for Q4 2019, with marketing activities targeting health care entities as well as the retail market.
The distributor Advanced Global Health markets and sells several innovative medical technology products in the women’s health segment in the UK. The company thus has a long experience and strong relationships with important entities in Efemia’s market segment.
“I look forward to the launch of Efemia in the UK, which will be the second major European market where the product will become available in 2019. We are pleased to be working with Advanced Global Health in the UK, as they share our passion to improve women’s health and quality of life through the use of innovative medical technology products,” says Invent Medic’s CEO Karin Bryder.
“Efemia is an innovative product with excellent timing, as many British women in different age groups are eager to adopt a more active lifestyle without having to worry about urine leakage. Based on this, we see a strong potential for Efemia, both in the national health care system and on the retail market,” says Advanced Global Health’s CEO Alexander Fisher.
It is reported that up to 50% of women experience stress urinary incontinence at some point during their lives. Based on this, the UK constitutes a substantial European market for Efemia with great potential. The agreement with Invent Medic enables Advanced Global Health to sell Efemia directly to consumers as well as to resellers and health care entities. Marketing activities in the UK will be targeting important occupational groups such as gynaecologists and incontinence physiotherapists as well as potential users.